Literature DB >> 15933417

Lessons learned from the edrecolomab story: how a checkered past became a checkered flag for monoclonal antibodies in colorectal cancer therapy.

Richard M Goldberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15933417     DOI： 10.1159/000085570

Source DB:  PubMed          Journal:  Onkologie        ISSN： 0378-584X


× No keyword cloud information.
  3 in total

1.  Heterodimeric bispecific single-chain variable-fragment antibodies against EpCAM and CD16 induce effective antibody-dependent cellular cytotoxicity against human carcinoma cells.

Authors:  Daniel A Vallera; Bin Zhang; Michelle K Gleason; Seunguk Oh; Louis M Weiner; Dan S Kaufman; Valarie McCullar; Jeffrey S Miller; Michael R Verneris
Journal:  Cancer Biother Radiopharm       Date:  2013-04-23       Impact factor: 3.099

2.  Reduction in membranous immunohistochemical staining for the intracellular domain of epithelial cell adhesion molecule correlates with poor patient outcome in primary colorectal adenocarcinoma.

Authors:  A Wang; R Ramjeesingh; C H Chen; D Hurlbut; N Hammad; L M Mulligan; C Nicol; H E Feilotter; S Davey
Journal:  Curr Oncol       Date:  2016-06-09       Impact factor: 3.677

3.  Side-by-side analysis of five clinically tested anti-EpCAM monoclonal antibodies.

Authors:  Markus Münz; Alexander Murr; Majk Kvesic; Doris Rau; Susanne Mangold; Stefan Pflanz; John Lumsden; Jörg Volkland; Jan Fagerberg; Gert Riethmüller; Dominik Rüttinger; Peter Kufer; Patrick A Baeuerle; Tobias Raum
Journal:  Cancer Cell Int       Date:  2010-11-02       Impact factor: 5.722
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.